NCPIC - National Cannabis Prevention and Information Centre

Publications Bulletin - May 2010

Relevant publications examining issues to do with cannabis that have been published in the last month include the following:

  • Barrigón, M.L., Gurpegui, M., Ruiz-Veguill, M., Diaz, F.J., Anguita, M., Sarramea, F., & Cervilla, J. (2010). Temporal relationship of first-episode non-affective psychosis with cannabis use: A clinical verification of an epidemiological hypothesis. Journal of Psychiatric Research 44, 413-420.
  • Battisti, R.A., Roodenrys, S., Johnstone, S.J., Respondek, C., Hermens, D.F., & Solowij, N. (2010). Chronic use of cannabis and poor neural efficiency in verbal memory ability. Psychopharmacology (Berl) 209, 319-330.
  • Becker, B., Wagner, D., Gouzoulis-Mayfrank, E., Spuentrup, E., & Daumann, J. (2010). Altered parahippocampal functioning in cannabis users is related to the frequency of use. Psychopharmacology (Berl) 209, 361-374.
  • Chandra, S., Lata, H., Mehmedic, Z., Khan, I.A., & ElSohly, M.A. (2010). Assessment of cannabinoids content in micropropagated plants of cannabis sativa and their comparison with conventionally propagated plants and mother plant during developmental stages of growth. Planta Medica 76, 743-750.
  • Cheung, J.T., Mann, R.E., Ialomiteanu, A., Stoduto, G., Chan, V., Ala-Leppilampi, K., & Rehm, J. (2010). Anxiety and mood disorders and cannabis use. The American Journal of Drug and Alcohol Abuse 36, 118-122.
  • de Dios, M.A., Anderson, B.J., Herman, D.S., Hagerty, C.E., Caviness, C.M., Budney, A.J., & Stein, M. (2010). Marijuana use subtypes in a community sample of young adult women. Women’s Health Issues 20, 201-210.
  • Eastwood, B., Bradley, B., Mogg, K., Tyler, E., & Field, M. (2010). Investigating the effects of a craving induction procedure on cognitive bias in cannabis users. American Journal on Addictions 19, 97-109.
  • Eggan, S.M., Mizoguchi, Y., Stoyak, S.R., & Lewis, D.A. (2010). Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cerebral Cortex 20, 1164-1174.
  • Farrimond, J.A., Hill, A.J., Whalley, B.J., & Williams, C.M. (2010). Cannabis constituents modulate Delta9-tetrahydrocannabinol-induced hyperphagia in rats. Psychopharmacology (Berl) 210, 97-106.
  • Fokos, S. & Panagis, G. (2010). Effects of Delta9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress. Journal of Psychopharmacology 24, 767-677.
  • Fusar-Poli, P., Allen, P., Bhattacharyya, S., Crippa, J.A., Mechelli, A., Borgwardt, S., Martin-Santos, R., Seal, M.L., O'Carrol, C., Atakan, Z., Zuardi, A.W., & McGuire, P. (2010). Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol. The International Journal of Neuropsychopharmacology 13, 421-432.
  • Greineisen, W.E. & Turner, H. (2010). Immunoactive effects of cannabinoids: Considerations for the therapeutic use of cannabinoid receptor agonists and antagonists. International Immunopharmacology 10, 547-555.
  • Huang, P., Liu-Chen, L.Y. & Kirby, L.G. (2010). Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze. Neuroscience Letters 475, 165-168.
  • Hurley, J.M., West, J.B. & Ehleringer, J.R. (2010). Tracing retail cannabis in the United States: Geographic origin and cultivation patterns. The International Journal on Drug Policy 21, 222-228.
  • Indig, D., Copeland, J., Conigrave, K.M., & Arcuri, A. (2010). Characteristics and comorbidity of drug and alcohol-related emergency department presentations detected by nursing triage text. Addiction 105, 897-906.
  • Johnson, K., Mullin, J., Marshall, E., Bonn-Miller, M., & Zvolensky, M. (2010). Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. The American Journal on Addictions 19, 277-282.
  • Jutras-Aswad, D., Zang, G. & Bruneau, J. (2010). Cannabis use correlates of syringe sharing among injection drug users. The American Journal on Addictions 19, 231-237.
  • Karschner, E.L., Barnes, A.J., Lowe, R.H., Scheidweiler, K.B., & Huestis, M.A. (2010). Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma. Analytical and Bioanalytical Chemistry 397, 603-611.
  • Lemstra, M., Bennett, N., Nannapaneni, U., Neudorf, C., Warren, L., Kershaw, T., & Scott, C. (2010). A systematic review of school-based marijuana and alcohol prevention programs targeting adolescents aged 10-15. Addiction Research and Theory 18, 84-96.
  • Lenné, M.G., Dietze, P.M., Triggs, T.J., Walmsley, S., Murphy, B., & Redman, J.R. (2010). The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand. Accident, Analysis and Prevention 42, 859-866.
  • Lenton, S. & Allsop, S. (2010). A tale of CIN – the cannabis infringement notice scheme in Western Australia. Addiction 105, 808-816.
  • Madhavaram, H. & Couch, R.A. (2010). Utilization of a detection level of 25 ng/mL for cannabinoids in urine using a CEDIA® THCPLUS immunoassay: Application of this cut-off to urines of school children. Forensic Science International 198, 28-30.
  • McGrath, J., Welham, J., Scott, J., Varghese, D., Degenhardt, L., Hayatbakhsh, M.R., Alati, R., Williams, G.M., Bor, W., & Najman, J.M. (2010). Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Archives of General Psychiatry 67, 440-447.
  • Mewton, L., Teesson, M. & Slade, T. (2010). "Youthful epidemic" or diagnostic bias? Differential item functioning of DSM-IV cannabis use criteria in an Australian general population survey. Addictive Behaviors 35, 408-413.
  • Müller, H., Sperling, W., Köhrmann, M., Huttner, H.B., Kornhuber, J., & Maler, J.M. (2010). The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research 118, 309-310.
  • Vorspan, F., Guillem, E., Bloch, V., Bellais, L., Sicot, R., Noble, F., Lepine, J.P., & Gorelick, D.A. (2010). Self-reported sleep disturbances during cannabis withdrawal in cannabis-dependent outpatients with and without opioid dependence. Sleep Medicine 11, 499-500.
  • Wille, S.M., Samyn, N., del Mar Ramírez-Fernández, M., & De Boeck, G. (2010). Evaluation of on-site oral fluid screening using Drugwipe-5+®, RapidSTAT® and Drug Test 5000® for the detection of drugs of abuse in drivers. Forensic Science International 198, 2-6.